Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluoxetine in progressive multiple sclerosis
NL-OMON23448Recruiting
- Sponsor
- Multiple Sclerosis Internationaal
- Start
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in multiple sclerosis (MS) comparing Fluoxetine with Placebo (2 arms). Primary endpoint: Number of patients with progression at 2 years. Started May 2006; status: recruiting.
02
Drugs
fluoxetine
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NL-OMON23448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON23448.